NCT02911298View on ClinicalTrials.gov

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 25, 2016

Primary Completion Date

March 6, 2017

Study Completion Date

March 6, 2017

Conditions
Healthy
Interventions
DRUG

Metronidazole Benzoate gastro-resistant capsule with radio-labelled mucoadhesive formulation

DRUG

Metronidazole Benzoate gastro-resistant capsule with radio-labelled non-mucoadhesive formulation

Trial Locations (1)

4031

University Hospital Basel, Phase I Research Unit, Basel

All Listed Sponsors
collaborator

Swiss Commission for Technology and Innovation

OTHER

collaborator

University of Basel

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

SocraTec R&D GmbH

OTHER

lead

Tillotts Pharma AG

INDUSTRY

NCT02911298 - Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules | Biotech Hunter | Biotech Hunter